Abstract
Treatment strategy for atrial fibrillation (AF) is a controversial matter. Catheter ablation is increasingly being used to treat patients with AF, and recent studies have reported success rates >80% for paroxysmal AF and >70% for persistent AF. The purpose of this work is to review the evidence supporting catheter ablation and compare it with pharmacological treatment in the management of AF.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Anti-Arrhythmia Agents / economics
-
Anti-Arrhythmia Agents / therapeutic use*
-
Atrial Fibrillation / complications
-
Atrial Fibrillation / economics
-
Atrial Fibrillation / therapy*
-
Catheter Ablation / adverse effects*
-
Catheter Ablation / economics
-
Catheter Ablation / statistics & numerical data*
-
Chronic Disease
-
Cost-Benefit Analysis
-
Heart Failure / complications
-
Humans
-
Practice Guidelines as Topic
-
Randomized Controlled Trials as Topic